Habico Invest A/S

Family Office Region of Southern Denmark, Denmark

Overview

Habico Invest A/S is a Danish family office established by Birgitte and Hans Bøgh-Sørensen, founders of Orifarm Group. The office manages the family's wealth through investments in private equity, venture capital, real estate, wine, and cars, emphasizing long-term value creation and strategic diversification. The family office employs a disciplined investment approach, allocating capital across multiple asset classes to preserve and grow family wealth. It supports long-term value creation through active portfolio management and strategic diversification. Habico Invest A/S leverages its experience in both public and private markets to support diversified wealth preservation, allocating capital with an emphasis on prudent stewardship and disciplined portfolio management.

Investment Focus

  • Long-term value creation
  • Strategic diversification
  • Prudent stewardship
  • Disciplined portfolio management

Portfolio Companies

Orifarm Group A/SPilatus Comparator SolutionsVimincoPharma WestenTakeda

Reach Habico Invest A/S directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Habico Invest A/S

What sectors does Habico Invest A/S invest in?

Habico Invest A/S invests in Technology, Healthcare, Consumer Goods, Pharmaceuticals and Manufacturing, and is based in Region of Southern Denmark, Denmark. Habico Invest A/S is listed as a family office in the ConnectSafely investor database.

What stage does Habico Invest A/S invest at?

Habico Invest A/S backs companies at Seed, Early Stage, Growth, Late Stage and Buyout, writing cheques of 1M - 50M.

Which regions does Habico Invest A/S invest in?

Habico Invest A/S invests across United States, United Kingdom, Germany, Denmark and Czech Republic.

What companies has Habico Invest A/S invested in?

Habico Invest A/S's portfolio includes Orifarm Group A/S, Pilatus Comparator Solutions, Viminco, Pharma Westen and Takeda.

Last updated · Source: ConnectSafely investor database